CClinicalTrials.gg
Not yet recruitingNCT07850440Updated Sep 30, 2026

Seton Re-routing for High Perianal Fistula

An interventional study of Seton Re-routing in High Perianal Fistula, Fistula-in-Ano and High Anal Fistula, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

High perianal fistulae involve a significant portion of the external anal sphincter muscle, making standard surgical fistulotomy risky due to the potential for postoperative fecal incontinence. Sphincter-preserving techniques aim to eradicate the fistula tract and promote healing while safeguarding anal continence.

The purpose of this prospective, single-arm clinical study is to evaluate the efficacy and safety of the two-stage seton re-routing technique in adult patients diagnosed with high perianal fistula at Assiut University Hospital.

The procedure is conducted in two stages:

  • First Stage: Identification and curettage of the fistula tract followed by placement of a loose draining seton to clear local sepsis and allow fibrous maturation over an interval of 6 to 12 weeks.
  • Second Stage: Creation of a low submucosal or intersphincteric tunnel beneath the main external anal sphincter complex. The seton is unthreaded and re-routed through this lower pathway, isolating the upper transsphincteric tract so it can heal spontaneously by secondary fibrosis. The resulting downstaged superficial tract is then laid open (low fistulotomy) or managed with staged seton tightening.

Participants will be monitored weekly during the first month, followed by regular monthly follow-up visits for a minimum of 6 to 9 months postoperatively. The study assesses complete fistula healing, recurrence rates, healing time, operative duration, postoperative complications, and anal continence status evaluated using the Cleveland Clinic (Wexner) Incontinence Score preoperatively and at 3, 6, and 9 months after surgery.

02

Conditions studied

  • High Perianal Fistula
  • Fistula-in-Ano
  • High Anal Fistula

Browse trials for

Keywords

  • Seton re-routing
  • Loose seton
  • Sphincter-sparing surgery
  • High transsphincteric fistula
  • Anal continence
  • Wexner incontinence score
  • Fistulotom
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 years or older, of either sex.
  • Diagnosed with high perianal fistula (fistula tract involving the upper two-thirds of the external anal sphincter).
  • De novo or recurrent perianal fistula.
  • American Society of Anesthesiologists (ASA) physical status classification I or II.

Exclusion criteria

Exclusion Criteria:

  • Fistula secondary to inflammatory bowel disease (Crohn's disease or ulcerative colitis), malignancy, tuberculosis, trauma, or prior pelvic irradiation.
  • Pre-existing fecal incontinence.
  • Uncontrolled diabetes mellitus or immunosuppressive conditions impairing wound healing.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    Two-Stage Seton Re-routing

    Participants undergo a two-stage seton re-routing procedure: (1) Stage 1: Under spinal or general anesthesia, identification and curettage of the tract followed by loose draining seton placement through the high fistula tract for 6-12 weeks to control sepsis and allow fibrotic maturation. (2) Stage 2: An incision is made in the intersphincteric plane beneath the main external anal sphincter body to create a low submucosal or intersphincteric tunnel toward the dentate line. The seton is untied and re-routed through this low pathway, isolating the high transsphincteric component to heal by secondary fibrosis. The resulting downstaged low superficial tract is either laid open immediately (low fistulotomy) or managed with staged seton tightening.

    Procedure: Seton Re-routing

Interventions

  • ProcedureSeton Re-routing

    A two-stage sphincter-sparing surgical procedure: Stage 1: Under spinal or general anesthesia, identification and curettage of the tract, followed by placement of a loose draining seton through the high fistula tract for 6 to 12 weeks to control local sepsis and promote fibrotic maturation. Stage 2: An incision is made in the intersphincteric plane beneath the main external anal sphincter body to create a low submucosal or intersphincteric tunnel toward the dentate line. The seton is untied and re-routed through this lower pathway, isolating the high transsphincteric component to heal spontaneously by secondary fibrosis. The resulting downstaged low tract is either laid open immediately (low fistulotomy) or managed by staged seton tightening.

05

What researchers measure

Primary outcomes

  1. Number of Participants With Complete Fistula Healing

    Complete fistula healing is defined as complete epithelialization and closure of both external and internal openings, with absence of discharge, pain, and induration on clinical examination.

    Time frame: 9 months

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07850440
Lead sponsor
Assiut University
Responsible party
Fady Medhat Moris (Resident, Assiut University) — Principal investigator
First posted
Sep 30, 2026
Start date
Oct 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Sep 30, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion